News stories about Hill-Rom Holdings (NYSE:HRC) have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hill-Rom Holdings earned a news sentiment score of 0.08 on Accern’s scale. Accern also gave news articles about the medical technology company an impact score of 46.9841681440798 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:
- Hill-Rom Holdings, Inc. – Value Analysis (NYSE:HRC) : November 14, 2017 (finance.yahoo.com)
- Hill-Rom Holdings, Inc. breached its 50 day moving average in a Bearish Manner : HRC-US : November 13, 2017 (finance.yahoo.com)
- Financial Contrast: Hill-Rom Holdings (HRC) vs. Its Peers (americanbankingnews.com)
- Hill-Rom Holdings Inc Declares Quarterly Dividend of $0.18 (HRC) (americanbankingnews.com)
- Hill-Rom Holdings Inc to Post Q1 2018 Earnings of $0.79 Per Share, Northcoast Research Forecasts (HRC) (americanbankingnews.com)
A number of research firms have issued reports on HRC. Cantor Fitzgerald set a $86.00 price objective on shares of Hill-Rom Holdings and gave the company a “hold” rating in a research report on Friday, July 28th. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research report on Monday, September 18th. Barclays PLC boosted their price objective on shares of Hill-Rom Holdings from $86.00 to $90.00 and gave the company an “overweight” rating in a research report on Monday, November 6th. BidaskClub cut shares of Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Finally, Needham & Company LLC decreased their price objective on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research report on Friday, July 28th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $88.57.
Hill-Rom Holdings (NYSE:HRC) opened at $76.93 on Wednesday. Hill-Rom Holdings has a 52-week low of $52.58 and a 52-week high of $84.65. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. The stock has a market cap of $5,055.03, a PE ratio of 19.88, a P/E/G ratio of 1.63 and a beta of 1.19.
Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.05. Hill-Rom Holdings had a net margin of 4.87% and a return on equity of 20.27%. The company had revenue of $738.30 million for the quarter, compared to analysts’ expectations of $731.10 million. During the same quarter in the previous year, the company earned $1.18 earnings per share. Hill-Rom Holdings’s quarterly revenue was up 4.6% on a year-over-year basis. research analysts forecast that Hill-Rom Holdings will post 4.26 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.94%. The ex-dividend date of this dividend is Thursday, December 14th. Hill-Rom Holdings’s dividend payout ratio is currently 36.18%.
In related news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $77.48, for a total transaction of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.